M. Meldal et al.
FULL PAPER
ure S3 in the Supporting Information). The swelling properties of the
resin after treatment with the reagents for two weeks were also com-
pared to the original properties. The resin did not dissolve under any of
these conditions and showed no changes in color or swelling, a result in-
dicating that no significant bond cleavage had occurred.
N-(2-Butyl)-N’-phenylthiourea (7): White crystalline solid (20.66 mg,
99.3%); m.p. 105–1068C; 1H NMR (250 MHz, CDCl3): d=0.83 (t, 3H),
1.09 (d, 3H), 1.35–1.48 (brs, 2H), 4.22–4.35 (brs, 1H), 5.65 (s, 1H), 7.05–
7.55 (brs, 5H) ppm; ESI MS: m/z calcd: 259.07; found: 259.1 [M+H]+.
N-(3-Pentyl)ethanamide (8): Colorless oil (12.84 mg, 99.5%); 1H NMR
(250 MHz, CDCl3): d=0.95 (t, 6H), 1.12–1.58 (brs, 4H), 1.68 (s, 3H),
2.91 (brs, 1H), 8.22 (s, 1H) ppm; ESI MS: m/z calcd: 130.12; found:
130.1 [M+H]+.
N-(3-Pentyl)hexanamide (9): Colorless oil (17.83 mg, 96.3%); 1H NMR
(250 MHz, CDCl3): d=0.81 (t, 3H), 1.02 (t, 6H), 1.11–1.25 (brs, 2H),
1.38–1.62 (brs, 4H), 1.66–1.88 (brs, 4H), 2.04 (t, 2H), 2.95 (brs, 1H),
8.25 (s, 1H) ppm; ESI MS: m/z calcd: 186.18; found: 186.1 [M+H]+.
Mechanical stability: A bead (300–500 mm) was placed between a ccd
camera lens and a cylindrical probe, connected to a strain gauge, to meas-
ure the force applied, and an actuator; the sample was then compressed
at a constant rate of 10 mmminꢀ1. The camera recorded the deformation
of the bead. An apparent compressive modulus (EA), can then be calcu-
lated as the ratio of the apparent compressive stress (sA, the force per
area of cross section of the bead) over the apparent compressive strain
(gA, the ratio of the diameter over the initial diameter).
N-(3-Pentyl)benzamide (10): White crystalline solid (18.12 mg, 94.8%);
m.p. 136–1378C; 1H NMR (250 MHz, CDCl3): d=1.02 (t, 6H), 1.39–1.68
(brs, 4H), 2.93 (brs, 1H), 7.25–7.65 (brs, 5H), 8.25 (s, 1H) ppm; ESI
MS: m/z calcd: 192.13; found: 192.1 [M+H]+.
Synthesis of ULTRAMINE-Red: The resin (500 mg, containing 1.6 mmol
of carbonyl groups) and boric acid (0.6 g, 9.6 mmol, 6 equiv) were meas-
ured into a reaction vessel. Trimethylborate (1 mL, 9.6 mmol, 6 equiv)
was added; this was followed by addition of 1m borane–THF complex
(32 mL, 20 equiv). After cessation of hydrogen evolution, the tubes were
capped tightly and kept in an oil bath at 658C for 72 h. The resin was
then filtered and washed with DMF (410 mL) and MeOH (410 mL).
The resin was suspended in piperidine (100%, 10 mL) and heated at
658C for 20 h to destroy the excess borane. The piperidine–borane solu-
tion was decanted, then the resin was washed with DMF (410 mL),
DCM (410 mL), and MeOH (410 mL) and dried under vacuum to
provide ULTRAMINE-Red with a quantitative conversion of amides to
amines, as monitored by the complete disappearance of the carbonyl
bands in the IR spectrum. Loadings are presented in Table 1; compres-
sive modulus: 0.45 MPa; color: transparent, pale yellow; IR: n˜ =3272.3
N-(4-Nitrophenyl)-N’-(3-pentyl)thiourea (11): Yellow crystalline solid
(24.78 mg, 92.8%); m.p. 112–1148C; 1H NMR (250 MHz, CDCl3): d=
0.88 (t, 6H), 1.45–1.69 (brs, 4H), 4.25 (brs, 1H), 7.23–7.61 (brs, 4H),
8.15 (brs, 2H) ppm; ESI MS: m/z calcd: 268.1; found: 268 [M+H]+.
9-Fluorenylmethyl-3-pentylcarbamate (12): White crystalline solid
(28.04 mg, 90.7%); m.p. 126–1288C; 1H NMR (250 MHz, CDCl3): d=
0.84 (t, 6H), 1.24–1.58 (brs, 4H), 3.48 (brs, 1H), 4.25 (t, 1H), 4.45 (d,
2H), 7.20–7.80 (brs, 8H) ppm; ESI MS: m/z calcd: 310.17; found: 310.1
[M+H]+.
2-Nitro-N-(3-pentyl)benzenesulfonamide (13): Brown crystalline solid
(25.52 mg, 93.8%); m.p. 178–1818C; 1H NMR (250 MHz, CDCl3): d=
0.74 (t, 6H), 1.28–1.68 (brs, 4H), 3.25 (brs, 1H), 5.05 (s, 1H), 7.61–8.18
(brs, 4H) ppm; ESI MS: m/z calcd: 223.12; found: 223.1 [M+H]+.
(NH stretch), 2937.6 (CH stretch) cmꢀ1
.
General procedure for acylation/scavenging: All the compounds were
synthesized simultaneously in a parallel arrangement (Table 2). Acylating
reagents (0.25 mmol) were added to 10 mL plastic vials, each containing
amine (0.1 mmol) in dry DCM (1 mL). Each vial was closed tightly, and
the mixture was agitated at room temperature with a shaker for 16 h.
ULTRAMINE (50 mg) was added to each vial and the solution was dilut-
ed to a volume of 3 mL with DCM. The resulting mixture was then agi-
tated for 6 h at room temperature and filtered. The resin was washed
with DCM (44 mL). The combined filtrate and washings were concen-
trated and transferred to a vial, and the solvent was removed with a
stream of argon. The resulting product was dried under vacuum over-
night to provide the product in almost quantitative yield. The purity of
each product was analyzed by HPLC (Table 2).
N-(2-Butyl)ethanamide (1): Colorless oil (11.47 mg, 99.7%); 1H NMR
(250 MHz, CDCl3): d=0.84 (t, 3H), 1.07 (d, 3H), 1.375–1.575 (brs, 2H),
1.88 (s, 3H), 3.97 (brs, 1H), 8.32 (s, 1H) ppm; ESI MS: m/z calcd: 116.1;
found: 116.1 [M+H]+.
N-(2-Butyl)hexanamide (2): Colorless oil (16.94 mg, 99.0%); 1H NMR
(250 MHz, CDCl3): d=0.84 (t, 3H), 0.88 (t, 3H), 1.12 (d, 3H), 1.23–1.37
(brs, 4H), 1.54–1.56 (brs, 4H), 2.05 (t, 2H), 3.84 (brs, 1H), 8.15 (s,
1H) ppm; ESI MS: m/z calcd: 172.16; found: 172.1 [M+H]+.
N-Phenyl-N’-(3-pentyl)thiourea (14): White crystalline solid (21.52 mg,
96.9%); m.p. 110–1128C; 1H NMR (250 MHz, CDCl3): d=0.85 (t, 6H),
1.28–1.54 (brs, 4H), 4.22 (brs, 1H), 7.26–7.66 (brs, 5H) ppm; ESI MS:
m/z calcd: 273.08; found: 273.1 [M+H]+.
N-(4-Nitrophenyl)ethanamide (15): Pale yellow crystalline solid
(17.91 mg, 99.5%); m.p. 212–2138C; 1H NMR (250 MHz, CDCl3): d=
2.13 (s, 3H), 7.55–7.62 (brs, 2H), 8.10–8.14 (brs, 2H) ppm; ESI MS: m/z
calcd: 181.05; found: 181 [M+H]+.
N-(4-Nitrophenyl)hexanamide (16): Pale yellow crystalline solid
(22.95 mg, 97.2%); m.p. 271–2738C; 1H NMR (250 MHz, CDCl3): d=
0.82 (t, 3H), 1.23–1.30 (brs, 4H), 1.65 (brs, 2H), 2.30 (t, 2H), 7.38 (s,
1H), 7.60–7.66 (brs, 2H), 8.10–8.18 (brs, 2H) ppm; ESI MS: m/z calcd:
237.12; found: 237 [M+H]+.
N-(4-Nitrophenyl)benzamide (17): Pale yellow crystalline solid (23.26 mg,
96.1%); m.p. 160–1628C; 1H NMR (250 MHz, CDCl3): d=7.30–7.60
(brs, 4H), 7.75–8.20 (brs, 5H) ppm; ESI MS: m/z calcd: 242.9; found:
243.0 [M+H]+.
N,N’-(Bis-4-nitrophenyl)thiourea (18): Yellow crystalline solid (29.38 mg,
92.4%); m.p. 186–1888C; 1H NMR (250 MHz, CDCl3): d=7.15–7.32
(brs, 4H), 7.92–8.20 (brs, 4H) ppm; ESI MS: m/z calcd: 319.04; found:
319 [M+H]+.
N-(2-Butyl)benzamide (3): White crystalline solid (17.57 mg, 99.2%);
m.p. 143–1458C; 1H NMR (250 MHz, CDCl3): d=0.88 (t, 3H), 1.12 (d,
3H), 1.38–1.65 (brs, 2H), 4.05 (brs, 1H), 7.31–7.72 (brs, 5H), 8.25 (s,
1H) ppm; ESI MS: m/z calcd: 178.12; found 178.1 [M+H]+.
9-Fluorenylmethyl-4-nitrophenylcarbamate (19): Pale yellow crystalline
solid (34.67 mg, 96.3%); m.p. 153–1558C; 1H NMR (250 MHz, CDCl3):
d=4.16 (d, 2H), 4.20 (brs, 1H), 7.01–7.75 (brs, 12H) ppm; ESI MS: m/z
calcd: 361.11; found: 361.1 [M+H]+.
N-(2-Butyl)-N’-(4-nitrophenyl)thiourea (4): Yellow crystalline solid
(24.37 mg, 96.3%); m.p. 119–1208C; 1H NMR (250 MHz, CDCl3): d=
0.89 (t, 3H), 1.15 (d, 3H), 1.55 (brs, 2H), 4.29 (brs, 1H), 7.18–8.15 (brs,
4H) ppm; ESI MS: m/z calcd: 254.09; found: 254.1 [M+H]+.
2-Nitro-N-(4-nitrophenyl)benzenesulfonamide (20): Brown crystalline
solid (26.53 mg, 97.2%); m.p. 252–2548C; 1H NMR (250 MHz, CDCl3):
d=7.45–7.88 (brs, 4H), 8.05–8.15 (brs, 4H) ppm; ESI MS: m/z calcd:
274.03; found: 274 [M+H]+.
N-(4-Nitrophenyl)-N’-phenylthiourea (21): Yellow crystalline solid
(32.04 mg, 99.2%); m.p. 144–1458C; 1H NMR (250 MHz, CDCl3): d=
7.10–7.22 (brs, 5H), 7.92–8.12 (brs, 4H) ppm; ESI MS: m/z calcd:
324.02; found: 324 [M+H]+.
9-Fluorenylmethyl-2-butylcarbamate (5): Pale yellow crystalline solid
(28.77 mg, 97.5%); m.p. 163–1658C; 1H NMR (250 MHz, CDCl3): d=
0.84 (t, 3H), 1.31 (d, 3H), 1.55–1.78 (brs, 2H), 4.1 (t, 1H), 4.20–4.35 (brs,
1H), 4.41 (d, 2H), 7.22–7.72 (brs, 8H), 8.23 (s, 1H) ppm; ESI MS: m/z
calcd: 296.16; found: 296.1 [M+H]+.
N-(3-Phenylpropyl)ethanamide (22): Colorless oil (17.65 mg, 99.5%);
1H NMR (250 MHz, CDCl3): d=1.72 (brs, 2H), 1.92 (s, 3H), 2.55 (brs,
2H), 3.23 (brs, 2H), 7.10–7.30 (brs, 5H), 8.05 (s, 1H) ppm; ESI MS: m/z
calcd: 178.12; found: 178.1 [M+H]+.
N-(2-Butyl)-2-nitrobenzenesulfonamide (6): Brown crystalline solid
(24.9 mg, 96.5%); m.p 181–1838C; 1H NMR (250 MHz, CDCl3): d=0.78
(t, 3H), 1.05 (d, 3H), 1.35–1.45 (brs, 2H), 3.31–3.58 (brs, 1H), 5.05 (s,
1H), 7.42–7.88 (brs, 4H) ppm; ESI MS: m/z calcd: 209.1; found 209.1
[M+H]+.
N-(3-Phenylpropyl)hexanamide (23): Colorless oil (22.71 mg, 97.4%);
1H NMR (250 MHz, CDCl3): d=0.82 (t, 3H), 1.15–1.25 (brs, 2H), 1.48
4414
ꢁ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 4407 – 4415